Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Wrist flexion and extension torques measured by highly sensitive dynamometer in healthy subjects from 5 to 80 years.

Decostre V, Canal A, Ollivier G, Ledoux I, Moraux A, Doppler V, Payan CA, Hogrel JY.

BMC Musculoskelet Disord. 2015 Jan 31;16:4. doi: 10.1186/s12891-015-0458-9.

2.

Attitudes and expectations of patients with neuromuscular diseases about their participation in a clinical trial.

Gargiulo M, Herson A, Michon CC, Hogrel JY, Doppler V, Laloui K, Herson S, Payan C, Eymard B, Laforêt P.

Rev Neurol (Paris). 2013 Aug-Sep;169(8-9):670-6. doi: 10.1016/j.neurol.2013.04.005. Epub 2013 Aug 22.

PMID:
23972818
3.

Ankle dorsi- and plantar-flexion torques measured by dynamometry in healthy subjects from 5 to 80 years.

Moraux A, Canal A, Ollivier G, Ledoux I, Doppler V, Payan C, Hogrel JY.

BMC Musculoskelet Disord. 2013 Mar 22;14:104. doi: 10.1186/1471-2474-14-104.

4.

Rigid spine syndrome revealing late-onset Pompe disease.

Laforêt P, Doppler V, Caillaud C, Laloui K, Claeys KG, Richard P, Ferreiro A, Eymard B.

Neuromuscul Disord. 2010 Feb;20(2):128-30. doi: 10.1016/j.nmd.2009.11.006. Epub 2009 Dec 14.

PMID:
20005713
5.

Periodic salbutamol in facioscapulohumeral muscular dystrophy: a randomized controlled trial.

Payan CA, Hogrel JY, Hammouda EH, Lacomblez L, Ollivier G, Doppler V, Eymard B, Attarian S, Pouget J, Desnuelle C, Laforêt P.

Arch Phys Med Rehabil. 2009 Jul;90(7):1094-101. doi: 10.1016/j.apmr.2008.12.027.

PMID:
19577021
6.

Dehydroepiandrosterone for myotonic dystrophy type 1.

Pénisson-Besnier I, Devillers M, Porcher R, Orlikowski D, Doppler V, Desnuelle C, Ferrer X, Bes MC, Bouhour F, Tranchant C, Lagrange E, Vershueren A, Uzenot D, Cintas P, Solé G, Hogrel JY, Laforêt P, Vial C, Vila AL, Sacconi S, Pouget J, Eymard B, Chevret S, Annane D.

Neurology. 2008 Aug 5;71(6):407-12. doi: 10.1212/01.wnl.0000324257.35759.40.

PMID:
18678823
7.

Development of a French isometric strength normative database for adults using quantitative muscle testing.

Hogrel JY, Payan CA, Ollivier G, Tanant V, Attarian S, Couillandre A, Dupeyron A, Lacomblez L, Doppler V, Meininger V, Tranchant C, Pouget J, Desnuelle C.

Arch Phys Med Rehabil. 2007 Oct;88(10):1289-97.

PMID:
17908571
8.

Xaliproden in amyotrophic lateral sclerosis: early clinical trials.

Lacomblez L, Bensimon G, Douillet P, Doppler V, Salachas F, Meininger V.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Jun;5(2):99-106.

PMID:
15204011
9.

[Tolerance of riluzole in a phase IIIb clinical trial].

Lacomblez L, Dib M, Doppler V, Faudet A, Robin V, Salachas F, Bensimon G, Meininger V.

Therapie. 2002 Jan-Feb;57(1):65-71. French.

PMID:
12090150
10.

APOE: a potential marker of disease progression in ALS.

Lacomblez L, Doppler V, Beucler I, Costes G, Salachas F, Raisonnier A, Le Forestier N, Pradat PF, Bruckert E, Meininger V.

Neurology. 2002 Apr 9;58(7):1112-4.

PMID:
11940705
11.

Blood oxidative stress in amyotrophic lateral sclerosis.

Bonnefont-Rousselot D, Lacomblez L, Jaudon M, Lepage S, Salachas F, Bensimon G, Bizard C, Doppler V, Delattre J, Meininger V.

J Neurol Sci. 2000 Sep 1;178(1):57-62.

PMID:
11018250
12.

Bullous pemphigoid and amyotrophic lateral sclerosis: a new clue for understanding the bullous disease?

Chosidow O, Doppler V, Bensimon G, Joly P, Salachas F, Lacomblez L, Prost C, Camu W, Francès C, Herson S, Meininger V.

Arch Dermatol. 2000 Apr;136(4):521-4. Review.

PMID:
10768651

Supplemental Content

Loading ...
Support Center